|
End-of-day quote
Korea S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 189,600.00 KRW | -2.27% |
|
-3.02% | +9.99% |
| 08-25 | Celltrion Launches Omlyclo 300 Mg Strength In Key European Markets | CI |
| 08-23 | Celltrion Submits Marketing Application for Keytruda Biosimilar in South Korea | MT |
ETFs positioned on Celltrion, Inc.
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +24.93% | -.--% | 182 M€ | |
| +11.77% | -.--% | 67 M€ | |
| +34.38% | -.--% | 2,017 M€ | |
| +28.70% | -.--% | 1,587 M€ | |
| +13.58% | -.--% | 27,154 M€ | |
| -.--% | 2.91% | 825 M€ | |
| +83.86% | 2.28% | 420 M€ | |
| +19.20% | 2.01% | 1,260 M€ | |
| +7.29% | 1.94% | 94 M€ | |
| +87.35% | 1.6% | 27,337 M€ | |
| +84.82% | 1.53% | 1,139 M€ | |
| +87.46% | 1.42% | 1,505 M€ | |
| +64.49% | 1.37% | 180 M€ | |
| +86.96% | 1.31% | 595 M€ | |
| +30.21% | 1.24% | 148 M€ | |
| +22.10% | 0.65% | 1,000 M€ | |
| +63.38% | 0.62% | 173 M€ | |
| +49.91% | 0.61% | 794 M€ | |
| +43.66% | 0.57% | 1,037 M€ | |
| +35.18% | 0.53% | 39 M€ | |
| +42.94% | 0.51% | 5,038 M€ | |
| -3.43% | 0.51% | 44 M€ | |
| +44.93% | 0.51% | 122 M€ | |
| +40.16% | 0.5% | 2,019 M€ | |
| +31.23% | 0.47% | 1,182 M€ | |
| +23.49% | 0.47% | 164 M€ | |
| +17.07% | 0.45% | 5 M€ | |
| +9.73% | 0.45% | 865 M€ | |
| +35.23% | 0.44% | 3,377 M€ | |
| +28.10% | 0.43% | 68 M€ | |
| +37.66% | 0.41% | 100 M€ | |
| +36.09% | 0.39% | 5,563 M€ | |
| +31.83% | 0.37% | 457 M€ | |
| +40.14% | 0.35% | 141 M€ | |
| +21.50% | 0.34% | 706 M€ | |
| +25.57% | 0.34% | 2,215 M€ |
Employees
2,680
- Stock Market
- Stocks
- A068270 Stock
- ETFs Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
